Life Sciences Tools and Services
Company Overview of STEMCELL Technologies, Inc.
STEMCELL Technologies, Inc., a biotechnology company, develops specialty cell culture media, cell separation products, and ancillary reagents for life science research applications. It offers cell isolation products, antibodies, cytokines, hybridoma generation and transfected cell selection products, primary cells, software, and stem cell detection kits. The company also provides contract assay, and stem cell culture training and education services; and customized cell culture and cell isolation courses. It distributes its products in Canada and internationally. STEMCELL Technologies, Inc. was founded in 1993 and is based in Vancouver, Canada. It has research, manufacturing, and shipping fac...
570 West 7th Avenue
Vancouver, BC V5Z 1B3
Founded in 1993
Key Executives for STEMCELL Technologies, Inc.
Chief Executive Officer and President
Compensation as of Fiscal Year 2015.
STEMCELL Technologies, Inc. Key Developments
STEMCELL Technologies Inc Launches Innovative Products to Support CAR T Cell Research
Jun 30 15
STEMCELL Technologies Inc. announced the launch of ImmunoCult Human T Cell Activator reagents and ImmunoCult -XF T Cell Expansion Medium to support T cell researchers in their goal to develop CAR T cell immunotherapeutics. The products provide significant benefits compared to existing technologies. ImmunoCult Human T Cell Activators are soluble reagents that elicit robust activation and expansion of T cells and are highly shelf-stable. The Activator reagents are optimized for use with the xeno- and serum-free ImmunoCult -XF T Cell Expansion Medium. Together, ImmunoCult T Cell Activator reagents and ImmunoCult -XF T Cell Expansion Medium promote a streamlined workflow for the ex vivo activation and expansion of human T cells. ImmunoCult Human T Cell Activator reagents and ImmunoCult -XF T Cell Expansion Medium build on STEMCELL’s existing portfolio of products to support T cell research, including the EasySep product line for immunomagnetic isolation of T cells. The new ImmunoCult products are currently for research use and STEMCELL is looking for partners to develop them for clinical applications.
The HUB Foundation for Organoid Technology and STEMCELL Technologies Sign Agreement on the Manufacturing of Cell Culture Media for Organoids
Jan 21 14
The HUB Foundation for Organoid Technology announced that it has signed a licensing agreement with STEMCELL Technologies Inc. for the manufacturing and worldwide distribution of cell culture media for growing Organoids. Organoids are mini-organs grown in tissue culture from small pieces of tissue derived from patients with cancer and other diseases, and represent an exciting new tool for scientific research and drug discovery and validation.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries